#GYNOnc
While discussing my continuing post chemo word retrieval problems w/the nurse practitioner at the GYNONC yesterday, she said, “Cancer treatment can be very emotionally traumatizing, adding to the problem.” First time I’ve been so directly validated.
#cansky #oncsky #cancerbs
February 1, 2025 at 4:12 PM
Hello, first post!

What are your favorite patient education resources for the HPV vaccine?

Shares would be greatly appreciated 😍 🙏 #RadOnc #MedOnc #GynOnc
November 22, 2024 at 3:09 PM
Help us welcome Drs. Katharine Linder and Daisy Cruz, our new CU GynOnc fellows joining the University of Colorado GynOnc Research Group (GORG) Lab this Fall 2025! Excited for the expertise and passion they'll bring to advancing women’s cancer research 🎉🎉 #GynOnc #CUAnschutz #OvarianCancer
August 18, 2025 at 6:14 PM
There was one #oncologist, my supervisor. He saw GI, brain, breast, ovarian #cancer. There was no #neuroonc, #gynonc specialists, etc. it was just him. The only lifeline these patients had.
That’s what knowing how to read paper maps gets you!
July 10, 2026 at 11:57 AM
Prof. Emerson Zaïrois #GynOnc #immunotherapist @roswellpark.bsky.social #buffalo talks on treatment for #endometrial #cancer / lots of slides/data. #olaparib # durva approved in Europe. Future? TIL, ADC #Bridge2024 @sitcancer.bsky.social @womenshealth365.bsky.social
December 5, 2024 at 9:41 AM
High-Grade Serous Carcinoma of the ovary, fallopian tube or peritoneum has the worst prognosis due to late diagnosis and therapy resistance. Dr. Alan Elder from the CU #GynOnc Lab aims to uncover the role of SEMA7A in therapy resistance and immunoevasion in ovarian cancer! @uccc-gorg.bsky.social
April 29, 2025 at 3:07 PM
Mourning the untimely passing of Giovanni Scambia – a visionary leader in European gynecologic oncology - Giuseppe Curigliano

oncodaily.com/blog/giovann...

#Cancer #Medicine #Health #Leadership #GynOnc #GynecologicOncology #Oncology #OncoDaily
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology - OncoDaily
Giuseppe Curigliano: Mourning the untimely passing of Giovanni Scambia - a visionary leader in European gynecologic oncology / cancer, Giovanni Scambia,
oncodaily.com
February 21, 2025 at 7:11 PM
Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial— new today from #JCOOA #oncsky #JCOOncologyAdvances #JCOJournals #gynonc
ascopubs.org/doi/10.1200/...
ASCO Publications
ascopubs.org
December 4, 2024 at 9:53 PM
📣ESMO #ClinicalPracticeGuideline Express Update on #EpithelialOvarianCancer:
- Rucaparib: 1st-line PARPi maintenance option
- MIRV: for recurrent FRα-high #OvarianCancer after 1-3 prior therapies & PFI <6 months

🔗 https://ow.ly/J06u50Y4HT8

#GYNOnc #Oncology #ESMOGuidelines
January 28, 2026 at 9:30 AM
Victoria’s Secret Global Fund for Women’s Cancers Career Development Award 2025: Advancing Research in Breast and Gynecologic Cancers

oncodaily.com/insight/vict...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GynOnc
Victoria’s Secret Global Fund for Women’s Cancers Career Development Award 2025: Advancing Research in Breast and Gynecologic Cancers - OncoDaily
Victoria’s Secret Global Fund for Women’s Cancers Career Development Award 2025: Advancing Research in Breast and Gynecologic Cancers / Breast Cancer
oncodaily.com
November 4, 2025 at 8:35 PM
Yesterday, CBS interviewed Dr. Kian Behbakht and AOA Dx, a Denver-based biotech startup, about their partnership to develop a unique ovarian cancer detection test in collaboration with the CU GynOnc Research Lab at CU Anschutz #CUAnschutz #OvarianCancer #GynOnc www.cbsnews.com/colorado/vid...
Women-founded company partners with CU Anschutz to develop ovarian cancer test
Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are on the cutting edge to detect and prevent ovarian cancer.
www.cbsnews.com
April 2, 2025 at 2:28 PM
Congrats to Drs. Ben Bitler and Jim Lambert on receiving an award from Golfers Against Cancer to advance ovarian cancer immunogenic cell death (ICD) research — pushing boundaries in cancer research #OvarianCancer #GynOnc #CUAnschutz 👏👏 @uccc-gorg.bsky.social
August 5, 2025 at 7:35 PM
After a chaotic day in the OR Friday, I really wanted to make this. Never in a million years did I imagine I’d be using my 7 years of design school to draw cheez-its….but here we are (not going to lie, pretty proud of how that cheez-it turned out 😂).
#medsky #obgyn #gynonc
February 27, 2025 at 2:45 AM
Dear Colleagues, Our Collaborators at COR2ED Invite you to watch Highlights from #ESMO25
WATCH HERE 👉 cor2ed.com/esmo-2025/br...

Straight from Berlin, Experts share their views on new data on #BreastCancer & #GynOnc
NOW ON DEMAND
October 23, 2025 at 10:02 AM
Excited to attend Oncofertility 2025 at Hammersmith Hospital! 🎗️ organised by my PhD mentor, Mr. Srdjan Saso, my work focuses on diagnosing ovarian cancer in pregnancy and children, so I’m eager to explore the latest in fertility preservation & gynae-oncology.
#Oncofertility2025 #GynOnc
March 4, 2025 at 9:50 AM
Drs. Ben Bitler & Kian Behbakht, AOA Dx (a women-owned Denver biotech), and other GynOnc researchers co-published a study on a scalable, sensitive test using lipidomic and protein biomarkers with machine learning to improve early ovarian cancer detection. View Here: www.mdpi.com/2075-4418/15...
www.mdpi.com
September 2, 2025 at 4:02 PM
Getting ready for St Patty’s Day. Who doesn’t need a speculum leprechaun 🍀?

It’s a redesign of one of the OG badge reels. Get yourself one and avoid being pinched this holiday 😂

#medsky #obgyn #gynonc
February 28, 2025 at 12:59 AM
Dr. Davidson submitted a proposal to the Boettcher Foundation! Single-cell sequencing revealed that High-grade serous carcinoma subtypes are driven by microenvironment changes. She seeks to redefine HGSC subtypes & assess functional impacts on biomarkers w/ chemotherapy.🤞#HGSC #GynOnc #CUAnschutz
March 19, 2025 at 3:09 PM
𝐌𝐈𝐑𝐕 𝐡𝐚𝐬 𝐭𝐡𝐞 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐭𝐨 𝐛𝐞𝐜𝐨𝐦𝐞 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐛𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫-𝐝𝐫𝐢𝐯𝐞𝐧 𝐬𝐭𝐚𝐧𝐝𝐚𝐫𝐝-𝐨𝐟-𝐜𝐚𝐫𝐞 𝐢𝐧 𝐏𝐑𝐎𝐂, 𝐩𝐚𝐫𝐭𝐢𝐜𝐮𝐥𝐚𝐫𝐥𝐲 𝐟𝐨𝐫 𝐅𝐑α-𝐡𝐢𝐠𝐡 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬.

#Onco404 #Oncology #ClinicalTrial #CancerResearch #TargetedTherapy #GynOnc #OvarianCancer #PlatinumResistant #Healthcare #EndCancer
March 14, 2025 at 8:43 AM
I had to go into surgical menopause (ovaries tried to kill me), and despite working in GYNONC(the group who performs the majority of these surgeries) I was still blindsided by a lot of changes to my body. Even with HRT
November 29, 2024 at 3:43 PM
This is encouraging. Reimbursement rates for OBGYN care are way too low. For instance, my #GynOnc friends explained that their surgeries are reimbursed less than similarly complex and time-consuming surgeries by other surgical specialties.

www.prnewswire.com/news-release...
Women's Health PAC Announces Significant Milestones Including Launch of First-ever Bipartisan Women's Health Reimbursement Summit, Strategic Growth Plans and Merger with Doctors For Fertility PAC
/PRNewswire/ -- Today, the Women's Health PAC (WHPAC), the first bipartisan organization dedicated to bridging the political divide to support increased...
www.prnewswire.com
February 6, 2025 at 2:30 AM